Transfusion and Haematology Today - Issue 4/2025
Editorial
Review/Educational Papers
253
Generational shift of the treatment of classical Hodgkin lymphoma
A. Sýkorová, H. Móciková, V. Procházka
269
279
287
Modern therapeutic approaches in the treatment of relapsed and refractory marginal zone lymphoma
J. Ďuraš, V. Procházka, A. Sýkorová
297
Follicular lymphoma – current perspective on treatment with emphasis on chemo free strategies
V. Procházka, K. Steinerová
Original Papers
305
Case Reports
311
Early isolated central nervous system relapse of mantle cell lymphoma successfully treated with ibrutinib and CAR T-cell therapy
A. Hrušková, R. Szotkowská, T. Papajík, A. Obr
Best Practices
317
Guidelines for the management of adverse events following CD19 CAR-T cell therapy in adult patients with lymphomas and acute lymphoblastic leukaemia – consensus of expert panel from certified centres in Czechia and Slovakia for 2025
F. Folber, F. Benkő, B. Čemusová, J. Vydra, K. Polgárová, M. Trněný, B. Víšek, J. M. Horáček, J. Šrámek, P. Jindra, J. Mihályová, M. Kaščák, Z. Rusiňáková, A. Vranovský, M. Čerňan, T. Szotkowski, V. Řivnáčová, H. Móciková, J. Sýkora, T. Guman, D. Belada, M. Doubek, L. Drgoňa, P. Lesný
327
European Congress on Thrombosis and Haemostasis 2025 – využitá příležitost
J. Gumulec, I. Demel, E. Drbohlavová, J. Blatný
331
334
Transfusion and Haematology Today
2025 Issue 4
Most read in this issue
- Guidelines for the management of adverse events following CD19 CAR-T cell therapy in adult patients with lymphomas and acute lymphoblastic leukaemia – consensus of expert panel from certified centres in Czechia and Slovakia for 2025
- Generational shift of the treatment of classical Hodgkin lymphoma
- Treatment of patients with relapsed or refractory diffuse large B-cell lymphoma in the Czech Republic in 2025
- Treatment of patients with relapsed or refractory diffuse large B-cell lymphoma in the Czech Republic in 2025